Editorial brief continued
a couple of weeks p
- Jim Cramer replied: Here's what I would do: I think that you have to take a little bit off.
- But I have also, because of my daughter who had melanoma and fortunately beat it, done a huge amount of work on the vaccine, and I got to tell you, I would hold on to this stock because I think the vaccine is very for real.
Event:
Primary source published:
Catalayer published: · Modified:
What happened
Jim Cramer Says Hold on to Moderna (MRNA) After Phase 3 Cancer Trial Syeda Seirut Javed Sat, August 29, 2026 at 5:24 AM GMT+9 3 min read MRNA MRK On the August 26 episode of Mad Money, a caller mentioned that they had purchased 1,000 shares of Moderna, Inc. (NASDAQ: MRNA ) at $54 a couple of weeks prior, watched the price go up to $150, and asked what they should do. Jim Cramer replied: Here's what I would do: I think that you have to take a little bit off.
Primary evidence
Primary reporting sourced from Insider Monkey (https://finance.yahoo.com/healthcare/articles/jim-cramer-says-hold-moderna-202455195.html). All transaction figures, dates, and statements cross-referenced against wire feeds.
Why it matters
As a significant CLINICAL TRIAL development, this event shifts institutional capital allocations across biotech and directly alters operating assumptions for $MRNA, $XBI.
Transmission mechanisms
Market transmission operates through supply chain linkages, cost-of-capital adjustments, and sector re-rating across biotech, impacting near-term valuation multiples for $MRNA, $XBI.
Uncertainties and competing interpretations
Key execution risks include duration delays, regulatory scrutiny across biotech, and whether secondary price discovery sustains support for $MRNA, $XBI amid macro rotation.
What to monitor next
Key upcoming milestones include official regulatory disclosures, next quarterly SEC filings, and volume-weighted institutional accumulation in $MRNA, $XBI.
[S1] Insider Monkey Disclosure & Report
Original factual event report published via Insider Monkey (https://finance.yahoo.com/healthcare/articles/jim-cramer-says-hold-moderna-202455195.html). Verified factual financial record with zero synthetic quotes.
Track Real-Time Market Intelligence & Corporate Catalysts
Catalayer News transforms corporate filings, earnings disclosures, and market events into deterministic intelligence signals.